TL;DR: Women’s health companies operate at the intersection of clinical complexity, cultural stigma, and fragmented stakeholder needs, and standard PR approaches often fall short. This article covers five strategies for building credibility and driving adoption: leading health conversations with authority, closing health literacy gaps through education, making data privacy a front-facing commitment, aligning messaging across patients, providers, and payers, and anchoring communications to clinical and systemic impact rather than product features.
Women’s health innovation, often referred to as femtech, has evolved from a niche category into one of the most significant growth opportunities in healthcare. (Even Mark Cuban agrees!)
In the U.S., that opportunity is especially notable.
Women drive the majority of healthcare decisions and spending, yet women’s health remains one of the most undercapitalized areas in the system, receiving only 6% of private healthcare investment.
That gap isn’t just a matter of equity. It’s a structural inefficiency in how care is funded, delivered and measured in the U.S.
It creates challenges for the companies building in this space and the industry leaders with a vision for a better system. Not only do they need to compete for limited investment, but they also have to overcome education gaps before they can drive adoption.
In today’s market, the challenge isn’t awareness. It’s adoption—and that requires a different approach to PR.
Women’s health companies sit at the intersection of cultural stigma, clinical validation, regulatory complexity and deeply personal experiences. As the industry moves beyond supporting specific stages in a woman’s lifecycle (e.g., fertility, pregnancy or menopause), innovators need to rethink how they communicate the interconnectedness of these moments.
They are not just marketing a product – they’re positioning how they fit across a patient’s care journey over time.
Here’s how:
1. Normalize the conversation, but lead it with authority.
Femtech includes everything from fertility to menopause care to maternal health and chronic condition management. A few years ago, simply breaking stigma was enough to stand out, especially in consumer markets. That’s changed. Today, the companies gaining traction are:
- Speaking clearly and directly about health issues
- Centering storytelling on real patient experiences, which sometimes includes partnering with influencers who are also real patients to strengthen brand authority
- Showing up as credible health partners, not just apps or devices
2. Focus on education to close the health literacy gap.
Awareness still lags, even as investment grows. We still see companies assume their audience understands the problem they’re solving. In reality, that’s often not the case – especially for conditions that are underdiagnosed or poorly understood. That’s where PR plays a critical role. Effective strategies will:
- Translate complex medical information into accessible language
- Clearly explain how solutions fit within a patient’s care journey
- Reinforce credibility with evidence and third-party expert validation
Education is not just a brand exercise. It’s directly tied to adoption.
3. Build trust through transparency and data privacy.
Women’s health companies should make privacy, data use, and security part of the core narrative, not something buried in the fine print. As more solutions rely on continuous data and AI, we’ve seen trust become a gating factor for patients and partners. To get ahead of this, companies should:
- Explain data practices in plain language
- Monitor the conversation through social listening and address concerns before they become mainstream
- Treat privacy as a core product feature, not just compliance
If you’re not proactively telling that story, it can quickly become a liability.
4. Demonstrate value across the healthcare ecosystem.
Many women’s health companies struggle to translate that value into provider adoption, health system prioritization, or payer reimbursement. That’s where things break down, especially in the U.S.
We’ve seen this play out repeatedly. Companies build strong engagement and brand awareness on the patient side but hit friction when they try to move into clinical or enterprise settings. Even some of the most well-known platforms in women’s health have had to make this shift, moving from consumer engagement to building clinical credibility and clearer alignment with providers and payers.
To drive adoption, companies need to clearly connect value across:
- Patients (experience, trust)
- Providers (clinical outcomes, workflow fit)
- Payers (cost, scalability, risk reduction)
We’ve seen strong products stall, not because of lack of demand, but because the story isn’t clear across stakeholders.
5. Lead with impact, not just innovation.
In a crowded digital health and medtech landscape, feature-driven messaging fades fast. What actually resonates is:
- Improved clinical outcomes
- Increased access to care
- Reduced system costs
- Better patient engagement
Your public relations program should always answer, “What changes for women because this exists?”
PR isn’t just about telling the story anymore. It’s about helping the right stakeholders understand, trust, and adopt what you’ve built.
